Letters, Testimony & Comments

Wed, 2007-11-07 02:00
BIO's comments to AHRQ regarding the Guide to Conducting Comparative Effectiveness Reviews
Mon, 2007-11-05 02:00
The Biotechnology Industry Organization Presents a Luncheon Seminar: From Biotechnology Innovation to Global Health Solutions: Solutions for Diseases Affecting Developing Countries Wednesday, 07 November 2007 13h00 to 15h00 Pavilion of...
Thu, 2007-11-01 15:20
Tue, 2007-10-30 01:00
The Comments of the Biotechnology Industry Organization on the United States Patent & Trademark Office Proposed Rule Changes Concerning Biological Deposits April 21, 2008 Comments to Proposed Rulemaking Entitled: Revision to the Time for...
Sat, 2007-10-27 01:00
BIO addresses concerns to FASB’s Staff Position on accounting for instrument C and conventional convertible debt.
Fri, 2007-10-26 01:00
BIO's comments regarding the Effectiveness and Off-Label Use of Recombinant Factor VIIa
Thu, 2007-10-25 01:00
Dear Speaker Pelosi, Rep. Obey, Rep. Lewis, and Rep. Walsh, On behalf of the undersigned organizations, representing the life sciences industry in California and nationwide, we urge you to support a funding level for the National Institutes of...
Wed, 2007-10-24 01:00
The Biotechnology Industry Organization (BIO) appreciates this opportunity to provide the perspective of its members on the role of federally-funded university research in the patent system. BIO represents over 1,100 companies, universities and...
Wed, 2007-10-17 01:00
COMMENTS OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) ON ISSUES TO BE ADDRESSED BY THE TECHNICAL EXPERTS GROUP ON CONCEPTS, TERMS, WORKING DEFINITIONS AND SECTORAL APPROACHES Introduction: Decision IX/12 of the Ninth Session of the Conference...
Tue, 2007-10-09 01:00
Attention: Kathleen Fonda Comments to Notice of Proposed Rulemaking Entitled: Examination of Patent Applications That Include Claims Containing Alternative Language Dear Ms. Fonda: The Biotechnology Industry Organization (BIO) appreciates...
Wed, 2007-10-03 01:00
The  Biotechnology Industry Organization (BIO) commends the WHO Intergovernmental Working Group on Public Health, Innovation and Intellectual Property ("IGWG") for undertaking the task of drawing up a global strategy and plan of...
Tue, 2007-09-18 01:00
BIO's comments on proposed changes to the 2009 HCPCS Level II Modification Process
Mon, 2007-09-17 01:00
BIO's comments on the Medicare Program; Meeting of the Medicare Evidence Development and Coverage Advisory Committee (MedCAC)
Fri, 2007-09-14 01:00
BIO's comments to CMS regarding proposed changes
Fri, 2007-09-07 01:00
Comments on Notice Regarding the 340B Pricing Program; Children's Hospitals